CSRXP APPLAUDS REINTRODUCTION OF FAIR DRUG PRICING ACT
Legislation Will Boost Transparency to Hold Big Pharma Accountable for… Read More
© 2026 CSRXP- All Rights Reserved
CSRXP WELCOMES U.S. SENATE HEARING ON OUT-OF-CONTROL PRESCRIPTION DRUG PRICES
Lawmakers on HELP Subcommittee Can Add to Bipartisan Momentum to Hold Big… Read More
CSRXP STATEMENT ON SENATE CONFIRMATION OF XAVIER BECERRA AS SECRETARY OF U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES
Campaign Looks Forward to Working with Secretary Becerra to Lower Drug Prices… Read More
CSRXP: POLICYMAKERS SHOULD TAKE NOTICE AS PFIZER DOUBLES DOWN ON PLANS TO HIKE VACCINE PRICE
Big Pharma CFO Hypes “Significant Opportunity” From “Pricing… Read More
BIG PHARMA WATCH: BIG PHARMA’S PRICE HIKES DROVE 50 PERCENT INCREASE IN MEDICARE SPENDING ON NEUROLOGIC DRUGS
New Study Finds Brand Name Price Increases Causing Spending Growth to Far… Read More
ICYMI: PHARMA-BACKED REBATE RULE THE WRONG MEDICINE FOR RX PRICES
Pharma-Backed Rebate Rule the Wrong Medicine for Rx Prices By Lauren Aronson… Read More
SECOND OPINION: PFIZER TALKS IMPORTANCE OF VACCINE AFFORDABILITY WHILE SIMULTANEOUSLY PLEDGING TO HIKE PRICES
Big Pharma CEO Says Price Should Never Be a Barrier After CFO Promised Company… Read More
CSRxP: PFIZER’S TONE-DEAF PLEDGE TO HIKE VACCINE PRICES HIGHLIGHTS URGENCY TO HOLD BIG PHARMA ACCOUNTABLE
Big Pharma Has Already Repeatedly Hiked Drug Prices During Public Health… Read More
DOSE OF REALITY: BIG PHARMA TO TESTIFY ON COVID-19 VACCINES AGAINST BACKDROP OF PANDEMIC PRICE HIKES AND BIG TIME PROFITS
Brand Name Drug Executives Should Commit to Affordable Pricing on COVID-19… Read More
BIG PHARMA WATCH: REPORT SHOWS DESPITE PANDEMIC, BIG PHARMA HAD A “TURBOCHARGED” YEAR IN 2020
Analysis Finds Drug Companies Posted Banner Year For Profits and Mergers While… Read More
BIG PHARMA EARNINGS WATCH: BRISTOL-MYERS SQUIBB, SANOFI, MERCK, ROCHE & ASTRAZENECA
Brand Name Pharma Companies Continue to Bring in Sky-High Profits While Hiking… Read More
CSRXP RELEASES MEMBER PACKET FOR 117TH CONGRESS
Resource Provides Information on Out-of-Control Drug Prices — Outlines… Read More